Page 5,729«..1020..5,7285,7295,7305,731..5,7405,750..»

Jamison: Stem cell promises and the heart

Posted: Published on February 9th, 2013

Since long before Ponce de Leon embarked on his infamous quest, man has been searching for the mythical fountain of youth. The latest quest, in the name of science, is stem-cell research. The idea is that you take a stem cell, inject it into a human and hope that it knows what to do and how to function. Thus, it will cure illness, restore tissue and prolong life. The miracle cure. Stem cells are truly magical in that they potentially contain the DNA for every structure in the body. The key is to unlock the code and tell the cell what to do and how to do it. In the field of cardiology, institutions, medical centers and pharmaceutical companies are banking on selling the public on stem cells. Billions of dollars, public relations and marketing are at stake. Unfortunately, the promises that have been made give people the false expectation that stem cells will save them and reverse the damage that unhealthy living has caused. Stem cells are complex. The process of teaching them to go to the correct tissue, express the correct DNA and incorporate themselves into healthy tissue is daunting at best. It is important to understand that … Continue reading

Posted in Stem Cell Research | Comments Off on Jamison: Stem cell promises and the heart

Partial fix found in mice for genetic disease

Posted: Published on February 9th, 2013

NEW ORLEANS (AP) - In a promising step against a genetic disease that causes deafness and gradual loss of vision, scientists have partly restored hearing with a single injection to young mice. Experts praised the study on Usher syndrome, published online last week by the journal Nature Medicine, but the results are still a long way from preventing the disease. Children with Usher _ an estimated one in 6,000 to 7,500 babies worldwide _ are born deaf. The visual component of the disease, called retinitis pigmentosa, often starts in childhood, but severe problems are more likely in adolescence and young adulthood. About half of adults with Usher can still read a newspaper into their 50s. Some groups, such as Louisianas Cajuns and Canadas Acadians, have an unusually high prevalence of the disease. In the study, Michelle Hastings of Chicago Medical School and Jennifer Lentz of the Louisiana State University Health Science Center found that one injection allowed affected mice to hear for months. The injection, or patch, is a laboratory-created fragment of RNA, which is a chemical cousin of DNA. The patch was designed to interfere with the effects of a faulty gene. Its a very promising and striking finding, … Continue reading

Comments Off on Partial fix found in mice for genetic disease

Genetic trigger for heart ailment

Posted: Published on February 9th, 2013

Genetic trigger for heart ailment (AFP) / 9 February 2013 A genetic variation doubles the risk of developing calcium deposits in the heart, a common condition that, in severe cases, can narrow or block the aorta, according to a study. The genetic variation, found in seven per cent of the population, provides important clues about how to treat the disease, researchers said in the study published in the New England Journal of Medicine. This is an important step forward in understanding the biology of the development of aortic stenosis, said senior author Wendy Post, from the Johns Hopkins University School of Medicine. She added that the latest findings could lead to the development of targeted medications to slow the progression of the disease, which can cause chest pain and shortness of breath, and can in some cases require surgery. The gene in question is involved in the production of a type of cholesterol particle called lipoprotein (a), which circulates in the blood. Increased levels of lipoprotein (a) have been previously associated with aortic valve disease. However, prior studies could not differentiate whether it was simply a marker or a causal factor, said lead author Catherine Campbell, of Kaiser Permanente. Our … Continue reading

Comments Off on Genetic trigger for heart ailment

Stem Cell Therapy Webinar with Dr. Kamau Kokayi at Patients Medical – Video

Posted: Published on February 9th, 2013

Stem Cell Therapy Webinar with Dr. Kamau Kokayi at Patients Medical Join us as Dr. Kamau Kokayi, Director of Cell Technologies at the New York Stem Cell Treatment Center at Patients Medical in NYC explains what Adipose Derived Stem Cell Therapy is and what types of medical conditions Dr. Kokayi and his team of researchers are enrolling for the clinical trial. By: PatientsMedicalNYC1 … Continue reading

Comments Off on Stem Cell Therapy Webinar with Dr. Kamau Kokayi at Patients Medical – Video

Bonita Springs stem-cell doctor asks judge to dismiss state's case against him

Posted: Published on February 9th, 2013

BONITA SPRINGS The defense for Bonita Springs doctor Zannos Grekos says a state complaint that he committed medical malpractice should be dismissed because prosecutors failed to show how his stem-cell therapy was below a standard of care or responsible for a patient's death, according to new court filings. Prosecutors with the Florida Department of Health also ignored a state law that patients have the right to seek out alternative medicine, said Richard Ozelie, the Boca Raton attorney for Grekos. That's what occurred with 69-year-old Domenica Fitzgerald, he said. "The Florida Legislature authorized its citizenry to seek out, as patients, either complementary or alternative modalities of treatment," he said Friday. Late Thursday, Ozelie filed a proposed order for Administrative Law Judge J. Lawrence Johnston to consider. The state submitted its proposed order this past Tuesday. The judge has 30 days to issue a recommendation to the Board of Medicine on potential discipline against Grekos, following a four-day hearing in October in Naples. The state wants Grekos' license revoked, a $40,000 fine imposed and $200,000 assessed for the state's costs. In 2010, Fitzgerald sought out stem-cell therapy with Grekos for numbness in her feet that was a side-effect several years earlier from … Continue reading

Comments Off on Bonita Springs stem-cell doctor asks judge to dismiss state's case against him

The International Myeloma Foundation Says Medical Innovation Is Helping Patients Live Longer, Better Lives

Posted: Published on February 9th, 2013

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)-- The International Myeloma Foundation (IMF) the oldest and largest foundation dedicated to improving the life and care of myeloma patients said POMALYST (pomalidomide) approval by the U.S. Food and Drug Administration will provide an important new option for patients who have exhausted all other treatments. POMALYST is an IMiDs compound, an immunomodulatory agent taken as an oral medication. It attacks the cancer in multiple ways, fighting the cells directly, as well as stimulating the immune system to aid cancer cell destruction. POMALYST is the first new oral cancer therapeutic approved for patients with multiple myeloma since REVLIMID was approved by the FDA in June 2006. The FDA decision follows the recent approval of KYPROLIS, a second-generation proteasome inhibitor for myeloma patients who have relapsed after previous therapies. In clinical trials, POMALYST and KYPROLIS also work together as a powerful new combination regimen. Brian G.M. Durie, M.D., Chairman and Co-founder of the IMF, states, With the novel therapies, many patients can experience long-term remissions. Since their introduction more than ten years ago, the median survival rate has increased from three years to nearly ten years because of these advances produced through medical innovation. However, when current drugs … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on The International Myeloma Foundation Says Medical Innovation Is Helping Patients Live Longer, Better Lives

Artificial bone created using stem cells and a new lightweight plastic could soon be used to heal broken limbs

Posted: Published on February 9th, 2013

Artificial bone degrades as new bone grows to replace it Team set to start trials on humans By Daily Mail Reporter PUBLISHED: 10:00 EST, 8 February 2013 | UPDATED: 10:00 EST, 8 February 2013 It only hurts when I laugh: The new healing technique could revolutionise healthcare Artificial bone created using stem cells and a new lightweight plastic could soon be used to heal broken limbs, according to scientists. The use of bone stem cells combined with a degradable rigid material inserted into shattered bones can encourage real bone to re-grow, they found. The plastic has a honeycomb-shaped scaffold structure to allow blood to flow through it, enabling stem cells from the patient's bone marrow to attach to it and grow new bone. Over time, the plastic slowly degrades as the implant is replaced by newly grown bone. The development was made by teams based at the Universities of Edinburgh and Southampton. They are now moving towards human clinical trials after successful results in the lab. Read more here: Artificial bone created using stem cells and a new lightweight plastic could soon be used to heal broken limbs … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Artificial bone created using stem cells and a new lightweight plastic could soon be used to heal broken limbs

MS treatment: Clinical trials due as human stem cells research shows promise

Posted: Published on February 9th, 2013

The first clinical trials of a revolutionary approach to treating multiple sclerosis with stem cells derived from the patients own skin could begin soon following research showing that it works well on laboratory mice, scientists said. A study has for the first time found that human skin cells converted into stem cells can be used to treat laboratory mice with a condition similar to multiple-sclerosis, where the fatty covering surrounding the nerves is lost. Scientists in the US said initial clinical trials on human patients using a similar approach could begin in 2015, with full-scale studies soon after. The skin cells were first genetically engineered to become induced pluripotent stem cells (iPS) before being converted to the specialised cells that make the fatty myelin sheaths, which insulate nerve cells in a similar way to the plastic covering of an electrical wire. The myelin is gradually degraded in MS patients. Scientists were able to turn the iPS cells into oligodendrocyte progenitor cells which were injected into the mice. These progenitor cells went on to become fully specialised oligodendrocytes, the cells responsible for making the myelin sheath. The new population of oligodendrocyte progenitor cells and oligodendrocytes was dense, abundant and complete. In … Continue reading

Posted in Stem Cell Human Trials | Comments Off on MS treatment: Clinical trials due as human stem cells research shows promise

ALS Patients’ Own Stem Cells Show Promise as a Future Treatment Option

Posted: Published on February 9th, 2013

Stem cells taken from ALS patients may have the same capacity to develop into mature neuron-like cells as those collected from healthy donors, according to a new study released this month in STEM CELLS Translational Medicine. These findings could open doors to a possible new treatment option while also reducing the chance for rejection and other side effects often seen when someone other than the patient is the cell donor. Durham, NC (PRWEB) February 08, 2013 Amyotrophic lateral sclerosis (ALS), or Lou Gehrigs Disease, is a rapidly deteriorating neurological condition affecting five out of every 100,000 people worldwide, mainly after the age of 50. The average survival time is only three years. While no effective treatment exists, preliminary studies suggest that the quality of life and even life expectancy itself could be improved in patients who receive stem cell infusions. However, questions remain about the capacity of these cells to take hold and turn into neurons. The study involved stem cells that bear the surface antigen CD133+, which have been shown to have a very low association with creating cancers. These cells can be isolated from a wide range of sources including bone marrow, peripheral blood and umbilical cord. A … Continue reading

Comments Off on ALS Patients’ Own Stem Cells Show Promise as a Future Treatment Option

Bonita Springs stem-cell doctor asks judge to dismiss state's case against him

Posted: Published on February 9th, 2013

BONITA SPRINGS The defense for Bonita Springs doctor Zannos Grekos says a state complaint that he committed medical malpractice should be dismissed because prosecutors failed to show how his stem-cell therapy was below a standard of care or responsible for a patient's death, according to new court filings. Prosecutors with the Florida Department of Health also ignored a state law that patients have the right to seek out alternative medicine, said Richard Ozelie, the Boca Raton attorney for Grekos. That's what occurred with 69-year-old Domenica Fitzgerald, he said. "The Florida Legislature authorized its citizenry to seek out, as patients, either complementary or alternative modalities of treatment," he said Friday. Late Thursday, Ozelie filed a proposed order for Administrative Law Judge J. Lawrence Johnston to consider. The state submitted its proposed order this past Tuesday. The judge has 30 days to issue a recommendation to the Board of Medicine on potential discipline against Grekos, following a four-day hearing in October in Naples. The state wants Grekos' license revoked, a $40,000 fine imposed and $200,000 assessed for the state's costs. In 2010, Fitzgerald sought out stem-cell therapy with Grekos for numbness in her feet that was a side-effect several years earlier from … Continue reading

Comments Off on Bonita Springs stem-cell doctor asks judge to dismiss state's case against him

Page 5,729«..1020..5,7285,7295,7305,731..5,7405,750..»